|
|
||||||||
Address correspondence to James T. Wu, Ph.D., ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108, USA; tel 801 583 2787; fax 801 584 5207; e-mail wuj{at}aruplab.com.
An ELISA for urine microalbumin using microtiter plates has been developed. The assay uses polyclonal anti-human albumin antibody for coating the microtiter plates and the same antibody conjugated with horseradish peroxidase for detection. The assay sensitivity is 1.6 µg/ml. Results by this in-house ELISA show good correlation (r = 0.99) with those obtained by a commercial assay using the Behring BNII autoanalyzer. Within-day and between-day CVs are 10%. R eference values for microalbumin in 769 urine specimens from healthy Chinese subjects were higher in women than men and higher in subjects 50 yr than in those <50 yr of age. Elevated mean concentrations of urine microalbumin were observed in patients with type 2 diabetes and CVD. This in-house ELISA is simple, sensitive, precise, and especially suited for laboratories without expensive autoanalyzers.
Keywords: enzyme-linked immunosorbent assay, type 2 diabetes, cardiovascular disease, microtiter plate assay, urine microalbumin
Abbreviations: BSA-PBS: phosphate buffer, 0.01 mol/L, pH 7.2, containing bovine serum albumin, 10 g/L; BNII, Behring Nephelometric Analyzer II; CRP, C-reactive protein; CVD, cardiovascular disease; ELISA, enzyme-linked immunosorbent assay; HRP, horse radish peroxidase; IL-6, interleukin-6; TNF-
, tumor necrosis factor-alpha; PBS, phosphate buffer, 0.1 mol/L, pH 7.2, containing NaCl, 0.14 mol/L, K-Blue, tetramethylbenzidine.
This article has been cited by other articles:
![]() |
J. T. Wu and L. L. Wu Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 240 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Chang, T.-L. Wu, K.-C. Tsao, C.-C. Li, C.-F. Sun, and J. T. Wu Microplate ELISAs for Soluble VCAM-1 and ICAM-1 Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 312 - 317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |